Medical Devices & Consumables
Global Continuous Glucose Monitoring (CGM) Market Research Report 2025
- Aug 20, 25
- ID: 458691
- Pages: 81
- Figures: 87
- Views: 1
Report Scope
This report aims to provide a comprehensive presentation of the global market for Continuous Glucose Monitoring (CGM), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Continuous Glucose Monitoring (CGM).
The Continuous Glucose Monitoring (CGM) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Continuous Glucose Monitoring (CGM) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Continuous Glucose Monitoring (CGM) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Pfizer
Baxter
Abbott Laboratories
Medtronic
Animas
Novo Nordisk
Ypsomed
GlySens
Segment by Type
Transmitters
Sensors
Insulin Pumps
Segment by Application
Hospitals
Homecare Settings
Others
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Continuous Glucose Monitoring (CGM) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Continuous Glucose Monitoring (CGM) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
This report aims to provide a comprehensive presentation of the global market for Continuous Glucose Monitoring (CGM), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Continuous Glucose Monitoring (CGM).
The Continuous Glucose Monitoring (CGM) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Continuous Glucose Monitoring (CGM) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Continuous Glucose Monitoring (CGM) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Pfizer
Baxter
Abbott Laboratories
Medtronic
Animas
Novo Nordisk
Ypsomed
GlySens
Segment by Type
Transmitters
Sensors
Insulin Pumps
Segment by Application
Hospitals
Homecare Settings
Others
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Continuous Glucose Monitoring (CGM) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Continuous Glucose Monitoring (CGM) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Continuous Glucose Monitoring (CGM) Market Overview
1.1 Product Definition
1.2 Continuous Glucose Monitoring (CGM) by Type
1.2.1 Global Continuous Glucose Monitoring (CGM) Market Value Comparison by Type (2024 VS 2031)
1.2.2 Transmitters
1.2.3 Sensors
1.2.4 Insulin Pumps
1.3 Continuous Glucose Monitoring (CGM) by Application
1.3.1 Global Continuous Glucose Monitoring (CGM) Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Homecare Settings
1.3.4 Others
1.4 Global Continuous Glucose Monitoring (CGM) Market Size Estimates and Forecasts
1.4.1 Global Continuous Glucose Monitoring (CGM) Revenue 2020-2031
1.4.2 Global Continuous Glucose Monitoring (CGM) Sales 2020-2031
1.4.3 Global Continuous Glucose Monitoring (CGM) Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Continuous Glucose Monitoring (CGM) Market Competition by Manufacturers
2.1 Global Continuous Glucose Monitoring (CGM) Sales Market Share by Manufacturers (2020-2025)
2.2 Global Continuous Glucose Monitoring (CGM) Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Continuous Glucose Monitoring (CGM) Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Continuous Glucose Monitoring (CGM), Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Continuous Glucose Monitoring (CGM), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Continuous Glucose Monitoring (CGM), Product Type & Application
2.7 Global Key Manufacturers of Continuous Glucose Monitoring (CGM), Date of Enter into This Industry
2.8 Global Continuous Glucose Monitoring (CGM) Market Competitive Situation and Trends
2.8.1 Global Continuous Glucose Monitoring (CGM) Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Continuous Glucose Monitoring (CGM) Players Market Share by Revenue
2.8.3 Global Continuous Glucose Monitoring (CGM) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Continuous Glucose Monitoring (CGM) Market Scenario by Region
3.1 Global Continuous Glucose Monitoring (CGM) Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Continuous Glucose Monitoring (CGM) Sales by Region: 2020-2031
3.2.1 Global Continuous Glucose Monitoring (CGM) Sales by Region: 2020-2025
3.2.2 Global Continuous Glucose Monitoring (CGM) Sales by Region: 2026-2031
3.3 Global Continuous Glucose Monitoring (CGM) Revenue by Region: 2020-2031
3.3.1 Global Continuous Glucose Monitoring (CGM) Revenue by Region: 2020-2025
3.3.2 Global Continuous Glucose Monitoring (CGM) Revenue by Region: 2026-2031
3.4 North America Continuous Glucose Monitoring (CGM) Market Facts & Figures by Country
3.4.1 North America Continuous Glucose Monitoring (CGM) Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Continuous Glucose Monitoring (CGM) Sales by Country (2020-2031)
3.4.3 North America Continuous Glucose Monitoring (CGM) Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Continuous Glucose Monitoring (CGM) Market Facts & Figures by Country
3.5.1 Europe Continuous Glucose Monitoring (CGM) Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Continuous Glucose Monitoring (CGM) Sales by Country (2020-2031)
3.5.3 Europe Continuous Glucose Monitoring (CGM) Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Continuous Glucose Monitoring (CGM) Market Facts & Figures by Region
3.6.1 Asia Pacific Continuous Glucose Monitoring (CGM) Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Continuous Glucose Monitoring (CGM) Sales by Region (2020-2031)
3.6.3 Asia Pacific Continuous Glucose Monitoring (CGM) Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Continuous Glucose Monitoring (CGM) Market Facts & Figures by Country
3.7.1 Latin America Continuous Glucose Monitoring (CGM) Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Continuous Glucose Monitoring (CGM) Sales by Country (2020-2031)
3.7.3 Latin America Continuous Glucose Monitoring (CGM) Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Continuous Glucose Monitoring (CGM) Market Facts & Figures by Country
3.8.1 Middle East and Africa Continuous Glucose Monitoring (CGM) Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Continuous Glucose Monitoring (CGM) Sales by Country (2020-2031)
3.8.3 Middle East and Africa Continuous Glucose Monitoring (CGM) Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Continuous Glucose Monitoring (CGM) Sales by Type (2020-2031)
4.1.1 Global Continuous Glucose Monitoring (CGM) Sales by Type (2020-2025)
4.1.2 Global Continuous Glucose Monitoring (CGM) Sales by Type (2026-2031)
4.1.3 Global Continuous Glucose Monitoring (CGM) Sales Market Share by Type (2020-2031)
4.2 Global Continuous Glucose Monitoring (CGM) Revenue by Type (2020-2031)
4.2.1 Global Continuous Glucose Monitoring (CGM) Revenue by Type (2020-2025)
4.2.2 Global Continuous Glucose Monitoring (CGM) Revenue by Type (2026-2031)
4.2.3 Global Continuous Glucose Monitoring (CGM) Revenue Market Share by Type (2020-2031)
4.3 Global Continuous Glucose Monitoring (CGM) Price by Type (2020-2031)
5 Segment by Application
5.1 Global Continuous Glucose Monitoring (CGM) Sales by Application (2020-2031)
5.1.1 Global Continuous Glucose Monitoring (CGM) Sales by Application (2020-2025)
5.1.2 Global Continuous Glucose Monitoring (CGM) Sales by Application (2026-2031)
5.1.3 Global Continuous Glucose Monitoring (CGM) Sales Market Share by Application (2020-2031)
5.2 Global Continuous Glucose Monitoring (CGM) Revenue by Application (2020-2031)
5.2.1 Global Continuous Glucose Monitoring (CGM) Revenue by Application (2020-2025)
5.2.2 Global Continuous Glucose Monitoring (CGM) Revenue by Application (2026-2031)
5.2.3 Global Continuous Glucose Monitoring (CGM) Revenue Market Share by Application (2020-2031)
5.3 Global Continuous Glucose Monitoring (CGM) Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Continuous Glucose Monitoring (CGM) Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Pfizer Continuous Glucose Monitoring (CGM) Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Baxter
6.2.1 Baxter Company Information
6.2.2 Baxter Description and Business Overview
6.2.3 Baxter Continuous Glucose Monitoring (CGM) Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Baxter Continuous Glucose Monitoring (CGM) Product Portfolio
6.2.5 Baxter Recent Developments/Updates
6.3 Abbott Laboratories
6.3.1 Abbott Laboratories Company Information
6.3.2 Abbott Laboratories Description and Business Overview
6.3.3 Abbott Laboratories Continuous Glucose Monitoring (CGM) Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Abbott Laboratories Continuous Glucose Monitoring (CGM) Product Portfolio
6.3.5 Abbott Laboratories Recent Developments/Updates
6.4 Medtronic
6.4.1 Medtronic Company Information
6.4.2 Medtronic Description and Business Overview
6.4.3 Medtronic Continuous Glucose Monitoring (CGM) Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Medtronic Continuous Glucose Monitoring (CGM) Product Portfolio
6.4.5 Medtronic Recent Developments/Updates
6.5 Animas
6.5.1 Animas Company Information
6.5.2 Animas Description and Business Overview
6.5.3 Animas Continuous Glucose Monitoring (CGM) Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Animas Continuous Glucose Monitoring (CGM) Product Portfolio
6.5.5 Animas Recent Developments/Updates
6.6 Novo Nordisk
6.6.1 Novo Nordisk Company Information
6.6.2 Novo Nordisk Description and Business Overview
6.6.3 Novo Nordisk Continuous Glucose Monitoring (CGM) Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Novo Nordisk Continuous Glucose Monitoring (CGM) Product Portfolio
6.6.5 Novo Nordisk Recent Developments/Updates
6.7 Ypsomed
6.7.1 Ypsomed Company Information
6.7.2 Ypsomed Description and Business Overview
6.7.3 Ypsomed Continuous Glucose Monitoring (CGM) Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Ypsomed Continuous Glucose Monitoring (CGM) Product Portfolio
6.7.5 Ypsomed Recent Developments/Updates
6.8 GlySens
6.8.1 GlySens Company Information
6.8.2 GlySens Description and Business Overview
6.8.3 GlySens Continuous Glucose Monitoring (CGM) Sales, Revenue and Gross Margin (2020-2025)
6.8.4 GlySens Continuous Glucose Monitoring (CGM) Product Portfolio
6.8.5 GlySens Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Continuous Glucose Monitoring (CGM) Industry Chain Analysis
7.2 Continuous Glucose Monitoring (CGM) Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Continuous Glucose Monitoring (CGM) Production Mode & Process Analysis
7.4 Continuous Glucose Monitoring (CGM) Sales and Marketing
7.4.1 Continuous Glucose Monitoring (CGM) Sales Channels
7.4.2 Continuous Glucose Monitoring (CGM) Distributors
7.5 Continuous Glucose Monitoring (CGM) Customer Analysis
8 Continuous Glucose Monitoring (CGM) Market Dynamics
8.1 Continuous Glucose Monitoring (CGM) Industry Trends
8.2 Continuous Glucose Monitoring (CGM) Market Drivers
8.3 Continuous Glucose Monitoring (CGM) Market Challenges
8.4 Continuous Glucose Monitoring (CGM) Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Continuous Glucose Monitoring (CGM) by Type
1.2.1 Global Continuous Glucose Monitoring (CGM) Market Value Comparison by Type (2024 VS 2031)
1.2.2 Transmitters
1.2.3 Sensors
1.2.4 Insulin Pumps
1.3 Continuous Glucose Monitoring (CGM) by Application
1.3.1 Global Continuous Glucose Monitoring (CGM) Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Homecare Settings
1.3.4 Others
1.4 Global Continuous Glucose Monitoring (CGM) Market Size Estimates and Forecasts
1.4.1 Global Continuous Glucose Monitoring (CGM) Revenue 2020-2031
1.4.2 Global Continuous Glucose Monitoring (CGM) Sales 2020-2031
1.4.3 Global Continuous Glucose Monitoring (CGM) Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Continuous Glucose Monitoring (CGM) Market Competition by Manufacturers
2.1 Global Continuous Glucose Monitoring (CGM) Sales Market Share by Manufacturers (2020-2025)
2.2 Global Continuous Glucose Monitoring (CGM) Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Continuous Glucose Monitoring (CGM) Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Continuous Glucose Monitoring (CGM), Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Continuous Glucose Monitoring (CGM), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Continuous Glucose Monitoring (CGM), Product Type & Application
2.7 Global Key Manufacturers of Continuous Glucose Monitoring (CGM), Date of Enter into This Industry
2.8 Global Continuous Glucose Monitoring (CGM) Market Competitive Situation and Trends
2.8.1 Global Continuous Glucose Monitoring (CGM) Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Continuous Glucose Monitoring (CGM) Players Market Share by Revenue
2.8.3 Global Continuous Glucose Monitoring (CGM) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Continuous Glucose Monitoring (CGM) Market Scenario by Region
3.1 Global Continuous Glucose Monitoring (CGM) Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Continuous Glucose Monitoring (CGM) Sales by Region: 2020-2031
3.2.1 Global Continuous Glucose Monitoring (CGM) Sales by Region: 2020-2025
3.2.2 Global Continuous Glucose Monitoring (CGM) Sales by Region: 2026-2031
3.3 Global Continuous Glucose Monitoring (CGM) Revenue by Region: 2020-2031
3.3.1 Global Continuous Glucose Monitoring (CGM) Revenue by Region: 2020-2025
3.3.2 Global Continuous Glucose Monitoring (CGM) Revenue by Region: 2026-2031
3.4 North America Continuous Glucose Monitoring (CGM) Market Facts & Figures by Country
3.4.1 North America Continuous Glucose Monitoring (CGM) Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Continuous Glucose Monitoring (CGM) Sales by Country (2020-2031)
3.4.3 North America Continuous Glucose Monitoring (CGM) Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Continuous Glucose Monitoring (CGM) Market Facts & Figures by Country
3.5.1 Europe Continuous Glucose Monitoring (CGM) Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Continuous Glucose Monitoring (CGM) Sales by Country (2020-2031)
3.5.3 Europe Continuous Glucose Monitoring (CGM) Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Continuous Glucose Monitoring (CGM) Market Facts & Figures by Region
3.6.1 Asia Pacific Continuous Glucose Monitoring (CGM) Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Continuous Glucose Monitoring (CGM) Sales by Region (2020-2031)
3.6.3 Asia Pacific Continuous Glucose Monitoring (CGM) Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Continuous Glucose Monitoring (CGM) Market Facts & Figures by Country
3.7.1 Latin America Continuous Glucose Monitoring (CGM) Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Continuous Glucose Monitoring (CGM) Sales by Country (2020-2031)
3.7.3 Latin America Continuous Glucose Monitoring (CGM) Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Continuous Glucose Monitoring (CGM) Market Facts & Figures by Country
3.8.1 Middle East and Africa Continuous Glucose Monitoring (CGM) Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Continuous Glucose Monitoring (CGM) Sales by Country (2020-2031)
3.8.3 Middle East and Africa Continuous Glucose Monitoring (CGM) Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Continuous Glucose Monitoring (CGM) Sales by Type (2020-2031)
4.1.1 Global Continuous Glucose Monitoring (CGM) Sales by Type (2020-2025)
4.1.2 Global Continuous Glucose Monitoring (CGM) Sales by Type (2026-2031)
4.1.3 Global Continuous Glucose Monitoring (CGM) Sales Market Share by Type (2020-2031)
4.2 Global Continuous Glucose Monitoring (CGM) Revenue by Type (2020-2031)
4.2.1 Global Continuous Glucose Monitoring (CGM) Revenue by Type (2020-2025)
4.2.2 Global Continuous Glucose Monitoring (CGM) Revenue by Type (2026-2031)
4.2.3 Global Continuous Glucose Monitoring (CGM) Revenue Market Share by Type (2020-2031)
4.3 Global Continuous Glucose Monitoring (CGM) Price by Type (2020-2031)
5 Segment by Application
5.1 Global Continuous Glucose Monitoring (CGM) Sales by Application (2020-2031)
5.1.1 Global Continuous Glucose Monitoring (CGM) Sales by Application (2020-2025)
5.1.2 Global Continuous Glucose Monitoring (CGM) Sales by Application (2026-2031)
5.1.3 Global Continuous Glucose Monitoring (CGM) Sales Market Share by Application (2020-2031)
5.2 Global Continuous Glucose Monitoring (CGM) Revenue by Application (2020-2031)
5.2.1 Global Continuous Glucose Monitoring (CGM) Revenue by Application (2020-2025)
5.2.2 Global Continuous Glucose Monitoring (CGM) Revenue by Application (2026-2031)
5.2.3 Global Continuous Glucose Monitoring (CGM) Revenue Market Share by Application (2020-2031)
5.3 Global Continuous Glucose Monitoring (CGM) Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Continuous Glucose Monitoring (CGM) Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Pfizer Continuous Glucose Monitoring (CGM) Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Baxter
6.2.1 Baxter Company Information
6.2.2 Baxter Description and Business Overview
6.2.3 Baxter Continuous Glucose Monitoring (CGM) Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Baxter Continuous Glucose Monitoring (CGM) Product Portfolio
6.2.5 Baxter Recent Developments/Updates
6.3 Abbott Laboratories
6.3.1 Abbott Laboratories Company Information
6.3.2 Abbott Laboratories Description and Business Overview
6.3.3 Abbott Laboratories Continuous Glucose Monitoring (CGM) Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Abbott Laboratories Continuous Glucose Monitoring (CGM) Product Portfolio
6.3.5 Abbott Laboratories Recent Developments/Updates
6.4 Medtronic
6.4.1 Medtronic Company Information
6.4.2 Medtronic Description and Business Overview
6.4.3 Medtronic Continuous Glucose Monitoring (CGM) Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Medtronic Continuous Glucose Monitoring (CGM) Product Portfolio
6.4.5 Medtronic Recent Developments/Updates
6.5 Animas
6.5.1 Animas Company Information
6.5.2 Animas Description and Business Overview
6.5.3 Animas Continuous Glucose Monitoring (CGM) Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Animas Continuous Glucose Monitoring (CGM) Product Portfolio
6.5.5 Animas Recent Developments/Updates
6.6 Novo Nordisk
6.6.1 Novo Nordisk Company Information
6.6.2 Novo Nordisk Description and Business Overview
6.6.3 Novo Nordisk Continuous Glucose Monitoring (CGM) Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Novo Nordisk Continuous Glucose Monitoring (CGM) Product Portfolio
6.6.5 Novo Nordisk Recent Developments/Updates
6.7 Ypsomed
6.7.1 Ypsomed Company Information
6.7.2 Ypsomed Description and Business Overview
6.7.3 Ypsomed Continuous Glucose Monitoring (CGM) Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Ypsomed Continuous Glucose Monitoring (CGM) Product Portfolio
6.7.5 Ypsomed Recent Developments/Updates
6.8 GlySens
6.8.1 GlySens Company Information
6.8.2 GlySens Description and Business Overview
6.8.3 GlySens Continuous Glucose Monitoring (CGM) Sales, Revenue and Gross Margin (2020-2025)
6.8.4 GlySens Continuous Glucose Monitoring (CGM) Product Portfolio
6.8.5 GlySens Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Continuous Glucose Monitoring (CGM) Industry Chain Analysis
7.2 Continuous Glucose Monitoring (CGM) Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Continuous Glucose Monitoring (CGM) Production Mode & Process Analysis
7.4 Continuous Glucose Monitoring (CGM) Sales and Marketing
7.4.1 Continuous Glucose Monitoring (CGM) Sales Channels
7.4.2 Continuous Glucose Monitoring (CGM) Distributors
7.5 Continuous Glucose Monitoring (CGM) Customer Analysis
8 Continuous Glucose Monitoring (CGM) Market Dynamics
8.1 Continuous Glucose Monitoring (CGM) Industry Trends
8.2 Continuous Glucose Monitoring (CGM) Market Drivers
8.3 Continuous Glucose Monitoring (CGM) Market Challenges
8.4 Continuous Glucose Monitoring (CGM) Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Continuous Glucose Monitoring (CGM) Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Continuous Glucose Monitoring (CGM) Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Continuous Glucose Monitoring (CGM) Market Competitive Situation by Manufacturers in 2024
Table 4. Global Continuous Glucose Monitoring (CGM) Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Continuous Glucose Monitoring (CGM) Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Continuous Glucose Monitoring (CGM) Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Continuous Glucose Monitoring (CGM) Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Continuous Glucose Monitoring (CGM) Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Continuous Glucose Monitoring (CGM), Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Continuous Glucose Monitoring (CGM), Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Continuous Glucose Monitoring (CGM), Product Type & Application
Table 12. Global Key Manufacturers of Continuous Glucose Monitoring (CGM), Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Continuous Glucose Monitoring (CGM) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Continuous Glucose Monitoring (CGM) as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Continuous Glucose Monitoring (CGM) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Continuous Glucose Monitoring (CGM) Sales by Region (2020-2025) & (K Units)
Table 18. Global Continuous Glucose Monitoring (CGM) Sales Market Share by Region (2020-2025)
Table 19. Global Continuous Glucose Monitoring (CGM) Sales by Region (2026-2031) & (K Units)
Table 20. Global Continuous Glucose Monitoring (CGM) Sales Market Share by Region (2026-2031)
Table 21. Global Continuous Glucose Monitoring (CGM) Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Continuous Glucose Monitoring (CGM) Revenue Market Share by Region (2020-2025)
Table 23. Global Continuous Glucose Monitoring (CGM) Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Continuous Glucose Monitoring (CGM) Revenue Market Share by Region (2026-2031)
Table 25. North America Continuous Glucose Monitoring (CGM) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Continuous Glucose Monitoring (CGM) Sales by Country (2020-2025) & (K Units)
Table 27. North America Continuous Glucose Monitoring (CGM) Sales by Country (2026-2031) & (K Units)
Table 28. North America Continuous Glucose Monitoring (CGM) Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Continuous Glucose Monitoring (CGM) Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Continuous Glucose Monitoring (CGM) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Continuous Glucose Monitoring (CGM) Sales by Country (2020-2025) & (K Units)
Table 32. Europe Continuous Glucose Monitoring (CGM) Sales by Country (2026-2031) & (K Units)
Table 33. Europe Continuous Glucose Monitoring (CGM) Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Continuous Glucose Monitoring (CGM) Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Continuous Glucose Monitoring (CGM) Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Continuous Glucose Monitoring (CGM) Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Continuous Glucose Monitoring (CGM) Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Continuous Glucose Monitoring (CGM) Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Continuous Glucose Monitoring (CGM) Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Continuous Glucose Monitoring (CGM) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Continuous Glucose Monitoring (CGM) Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Continuous Glucose Monitoring (CGM) Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Continuous Glucose Monitoring (CGM) Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Continuous Glucose Monitoring (CGM) Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Continuous Glucose Monitoring (CGM) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Continuous Glucose Monitoring (CGM) Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Continuous Glucose Monitoring (CGM) Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Continuous Glucose Monitoring (CGM) Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Continuous Glucose Monitoring (CGM) Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Continuous Glucose Monitoring (CGM) Sales (K Units) by Type (2020-2025)
Table 51. Global Continuous Glucose Monitoring (CGM) Sales (K Units) by Type (2026-2031)
Table 52. Global Continuous Glucose Monitoring (CGM) Sales Market Share by Type (2020-2025)
Table 53. Global Continuous Glucose Monitoring (CGM) Sales Market Share by Type (2026-2031)
Table 54. Global Continuous Glucose Monitoring (CGM) Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Continuous Glucose Monitoring (CGM) Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Continuous Glucose Monitoring (CGM) Revenue Market Share by Type (2020-2025)
Table 57. Global Continuous Glucose Monitoring (CGM) Revenue Market Share by Type (2026-2031)
Table 58. Global Continuous Glucose Monitoring (CGM) Price (USD/Unit) by Type (2020-2025)
Table 59. Global Continuous Glucose Monitoring (CGM) Price (USD/Unit) by Type (2026-2031)
Table 60. Global Continuous Glucose Monitoring (CGM) Sales (K Units) by Application (2020-2025)
Table 61. Global Continuous Glucose Monitoring (CGM) Sales (K Units) by Application (2026-2031)
Table 62. Global Continuous Glucose Monitoring (CGM) Sales Market Share by Application (2020-2025)
Table 63. Global Continuous Glucose Monitoring (CGM) Sales Market Share by Application (2026-2031)
Table 64. Global Continuous Glucose Monitoring (CGM) Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Continuous Glucose Monitoring (CGM) Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Continuous Glucose Monitoring (CGM) Revenue Market Share by Application (2020-2025)
Table 67. Global Continuous Glucose Monitoring (CGM) Revenue Market Share by Application (2026-2031)
Table 68. Global Continuous Glucose Monitoring (CGM) Price (USD/Unit) by Application (2020-2025)
Table 69. Global Continuous Glucose Monitoring (CGM) Price (USD/Unit) by Application (2026-2031)
Table 70. Pfizer Company Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Continuous Glucose Monitoring (CGM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 73. Pfizer Continuous Glucose Monitoring (CGM) Product
Table 74. Pfizer Recent Developments/Updates
Table 75. Baxter Company Information
Table 76. Baxter Description and Business Overview
Table 77. Baxter Continuous Glucose Monitoring (CGM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 78. Baxter Continuous Glucose Monitoring (CGM) Product
Table 79. Baxter Recent Developments/Updates
Table 80. Abbott Laboratories Company Information
Table 81. Abbott Laboratories Description and Business Overview
Table 82. Abbott Laboratories Continuous Glucose Monitoring (CGM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Abbott Laboratories Continuous Glucose Monitoring (CGM) Product
Table 84. Abbott Laboratories Recent Developments/Updates
Table 85. Medtronic Company Information
Table 86. Medtronic Description and Business Overview
Table 87. Medtronic Continuous Glucose Monitoring (CGM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Medtronic Continuous Glucose Monitoring (CGM) Product
Table 89. Medtronic Recent Developments/Updates
Table 90. Animas Company Information
Table 91. Animas Description and Business Overview
Table 92. Animas Continuous Glucose Monitoring (CGM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Animas Continuous Glucose Monitoring (CGM) Product
Table 94. Animas Recent Developments/Updates
Table 95. Novo Nordisk Company Information
Table 96. Novo Nordisk Description and Business Overview
Table 97. Novo Nordisk Continuous Glucose Monitoring (CGM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Novo Nordisk Continuous Glucose Monitoring (CGM) Product
Table 99. Novo Nordisk Recent Developments/Updates
Table 100. Ypsomed Company Information
Table 101. Ypsomed Description and Business Overview
Table 102. Ypsomed Continuous Glucose Monitoring (CGM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Ypsomed Continuous Glucose Monitoring (CGM) Product
Table 104. Ypsomed Recent Developments/Updates
Table 105. GlySens Company Information
Table 106. GlySens Description and Business Overview
Table 107. GlySens Continuous Glucose Monitoring (CGM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. GlySens Continuous Glucose Monitoring (CGM) Product
Table 109. GlySens Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Continuous Glucose Monitoring (CGM) Distributors List
Table 113. Continuous Glucose Monitoring (CGM) Customers List
Table 114. Continuous Glucose Monitoring (CGM) Market Trends
Table 115. Continuous Glucose Monitoring (CGM) Market Drivers
Table 116. Continuous Glucose Monitoring (CGM) Market Challenges
Table 117. Continuous Glucose Monitoring (CGM) Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
Table 121. Authors List of This Report
List of Figures
Figure 1. Product Picture of Continuous Glucose Monitoring (CGM)
Figure 2. Global Continuous Glucose Monitoring (CGM) Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Continuous Glucose Monitoring (CGM) Market Share by Type: 2024 & 2031
Figure 4. Transmitters Product Picture
Figure 5. Sensors Product Picture
Figure 6. Insulin Pumps Product Picture
Figure 7. Global Continuous Glucose Monitoring (CGM) Market Value by Application (2020-2031) & (US$ Million)
Figure 8. Global Continuous Glucose Monitoring (CGM) Market Share by Application: 2024 & 2031
Figure 9. Hospitals
Figure 10. Homecare Settings
Figure 11. Others
Figure 12. Global Continuous Glucose Monitoring (CGM) Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Continuous Glucose Monitoring (CGM) Market Size (2020-2031) & (US$ Million)
Figure 14. Global Continuous Glucose Monitoring (CGM) Sales (2020-2031) & (K Units)
Figure 15. Global Continuous Glucose Monitoring (CGM) Average Price (USD/Unit) & (2020-2031)
Figure 16. Continuous Glucose Monitoring (CGM) Report Years Considered
Figure 17. Continuous Glucose Monitoring (CGM) Sales Share by Manufacturers in 2024
Figure 18. Global Continuous Glucose Monitoring (CGM) Revenue Share by Manufacturers in 2024
Figure 19. Global 5 and 10 Largest Continuous Glucose Monitoring (CGM) Players: Market Share by Revenue in Continuous Glucose Monitoring (CGM) in 2024
Figure 20. Continuous Glucose Monitoring (CGM) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 21. Global Continuous Glucose Monitoring (CGM) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 22. North America Continuous Glucose Monitoring (CGM) Sales Market Share by Country (2020-2031)
Figure 23. North America Continuous Glucose Monitoring (CGM) Revenue Market Share by Country (2020-2031)
Figure 24. U.S. Continuous Glucose Monitoring (CGM) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Canada Continuous Glucose Monitoring (CGM) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Europe Continuous Glucose Monitoring (CGM) Sales Market Share by Country (2020-2031)
Figure 27. Europe Continuous Glucose Monitoring (CGM) Revenue Market Share by Country (2020-2031)
Figure 28. Germany Continuous Glucose Monitoring (CGM) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. France Continuous Glucose Monitoring (CGM) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. U.K. Continuous Glucose Monitoring (CGM) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Italy Continuous Glucose Monitoring (CGM) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Russia Continuous Glucose Monitoring (CGM) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Asia Pacific Continuous Glucose Monitoring (CGM) Sales Market Share by Region (2020-2031)
Figure 34. Asia Pacific Continuous Glucose Monitoring (CGM) Revenue Market Share by Region (2020-2031)
Figure 35. China Continuous Glucose Monitoring (CGM) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Japan Continuous Glucose Monitoring (CGM) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. South Korea Continuous Glucose Monitoring (CGM) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. India Continuous Glucose Monitoring (CGM) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Australia Continuous Glucose Monitoring (CGM) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Taiwan Continuous Glucose Monitoring (CGM) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Indonesia Continuous Glucose Monitoring (CGM) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Thailand Continuous Glucose Monitoring (CGM) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Malaysia Continuous Glucose Monitoring (CGM) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Philippines Continuous Glucose Monitoring (CGM) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Latin America Continuous Glucose Monitoring (CGM) Sales Market Share by Country (2020-2031)
Figure 46. Latin America Continuous Glucose Monitoring (CGM) Revenue Market Share by Country (2020-2031)
Figure 47. Mexico Continuous Glucose Monitoring (CGM) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Brazil Continuous Glucose Monitoring (CGM) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Argentina Continuous Glucose Monitoring (CGM) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Middle East and Africa Continuous Glucose Monitoring (CGM) Sales Market Share by Country (2020-2031)
Figure 51. Middle East and Africa Continuous Glucose Monitoring (CGM) Revenue Market Share by Country (2020-2031)
Figure 52. Turkey Continuous Glucose Monitoring (CGM) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Saudi Arabia Continuous Glucose Monitoring (CGM) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. U.A.E Continuous Glucose Monitoring (CGM) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Global Sales Market Share of Continuous Glucose Monitoring (CGM) by Type (2020-2031)
Figure 56. Global Revenue Market Share of Continuous Glucose Monitoring (CGM) by Type (2020-2031)
Figure 57. Global Continuous Glucose Monitoring (CGM) Price (USD/Unit) by Type (2020-2031)
Figure 58. Global Sales Market Share of Continuous Glucose Monitoring (CGM) by Application (2020-2031)
Figure 59. Global Revenue Market Share of Continuous Glucose Monitoring (CGM) by Application (2020-2031)
Figure 60. Global Continuous Glucose Monitoring (CGM) Price (USD/Unit) by Application (2020-2031)
Figure 61. Continuous Glucose Monitoring (CGM) Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Table 1. Global Continuous Glucose Monitoring (CGM) Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Continuous Glucose Monitoring (CGM) Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Continuous Glucose Monitoring (CGM) Market Competitive Situation by Manufacturers in 2024
Table 4. Global Continuous Glucose Monitoring (CGM) Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Continuous Glucose Monitoring (CGM) Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Continuous Glucose Monitoring (CGM) Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Continuous Glucose Monitoring (CGM) Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Continuous Glucose Monitoring (CGM) Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Continuous Glucose Monitoring (CGM), Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Continuous Glucose Monitoring (CGM), Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Continuous Glucose Monitoring (CGM), Product Type & Application
Table 12. Global Key Manufacturers of Continuous Glucose Monitoring (CGM), Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Continuous Glucose Monitoring (CGM) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Continuous Glucose Monitoring (CGM) as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Continuous Glucose Monitoring (CGM) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Continuous Glucose Monitoring (CGM) Sales by Region (2020-2025) & (K Units)
Table 18. Global Continuous Glucose Monitoring (CGM) Sales Market Share by Region (2020-2025)
Table 19. Global Continuous Glucose Monitoring (CGM) Sales by Region (2026-2031) & (K Units)
Table 20. Global Continuous Glucose Monitoring (CGM) Sales Market Share by Region (2026-2031)
Table 21. Global Continuous Glucose Monitoring (CGM) Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Continuous Glucose Monitoring (CGM) Revenue Market Share by Region (2020-2025)
Table 23. Global Continuous Glucose Monitoring (CGM) Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Continuous Glucose Monitoring (CGM) Revenue Market Share by Region (2026-2031)
Table 25. North America Continuous Glucose Monitoring (CGM) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Continuous Glucose Monitoring (CGM) Sales by Country (2020-2025) & (K Units)
Table 27. North America Continuous Glucose Monitoring (CGM) Sales by Country (2026-2031) & (K Units)
Table 28. North America Continuous Glucose Monitoring (CGM) Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Continuous Glucose Monitoring (CGM) Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Continuous Glucose Monitoring (CGM) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Continuous Glucose Monitoring (CGM) Sales by Country (2020-2025) & (K Units)
Table 32. Europe Continuous Glucose Monitoring (CGM) Sales by Country (2026-2031) & (K Units)
Table 33. Europe Continuous Glucose Monitoring (CGM) Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Continuous Glucose Monitoring (CGM) Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Continuous Glucose Monitoring (CGM) Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Continuous Glucose Monitoring (CGM) Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Continuous Glucose Monitoring (CGM) Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Continuous Glucose Monitoring (CGM) Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Continuous Glucose Monitoring (CGM) Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Continuous Glucose Monitoring (CGM) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Continuous Glucose Monitoring (CGM) Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Continuous Glucose Monitoring (CGM) Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Continuous Glucose Monitoring (CGM) Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Continuous Glucose Monitoring (CGM) Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Continuous Glucose Monitoring (CGM) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Continuous Glucose Monitoring (CGM) Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Continuous Glucose Monitoring (CGM) Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Continuous Glucose Monitoring (CGM) Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Continuous Glucose Monitoring (CGM) Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Continuous Glucose Monitoring (CGM) Sales (K Units) by Type (2020-2025)
Table 51. Global Continuous Glucose Monitoring (CGM) Sales (K Units) by Type (2026-2031)
Table 52. Global Continuous Glucose Monitoring (CGM) Sales Market Share by Type (2020-2025)
Table 53. Global Continuous Glucose Monitoring (CGM) Sales Market Share by Type (2026-2031)
Table 54. Global Continuous Glucose Monitoring (CGM) Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Continuous Glucose Monitoring (CGM) Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Continuous Glucose Monitoring (CGM) Revenue Market Share by Type (2020-2025)
Table 57. Global Continuous Glucose Monitoring (CGM) Revenue Market Share by Type (2026-2031)
Table 58. Global Continuous Glucose Monitoring (CGM) Price (USD/Unit) by Type (2020-2025)
Table 59. Global Continuous Glucose Monitoring (CGM) Price (USD/Unit) by Type (2026-2031)
Table 60. Global Continuous Glucose Monitoring (CGM) Sales (K Units) by Application (2020-2025)
Table 61. Global Continuous Glucose Monitoring (CGM) Sales (K Units) by Application (2026-2031)
Table 62. Global Continuous Glucose Monitoring (CGM) Sales Market Share by Application (2020-2025)
Table 63. Global Continuous Glucose Monitoring (CGM) Sales Market Share by Application (2026-2031)
Table 64. Global Continuous Glucose Monitoring (CGM) Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Continuous Glucose Monitoring (CGM) Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Continuous Glucose Monitoring (CGM) Revenue Market Share by Application (2020-2025)
Table 67. Global Continuous Glucose Monitoring (CGM) Revenue Market Share by Application (2026-2031)
Table 68. Global Continuous Glucose Monitoring (CGM) Price (USD/Unit) by Application (2020-2025)
Table 69. Global Continuous Glucose Monitoring (CGM) Price (USD/Unit) by Application (2026-2031)
Table 70. Pfizer Company Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Continuous Glucose Monitoring (CGM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 73. Pfizer Continuous Glucose Monitoring (CGM) Product
Table 74. Pfizer Recent Developments/Updates
Table 75. Baxter Company Information
Table 76. Baxter Description and Business Overview
Table 77. Baxter Continuous Glucose Monitoring (CGM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 78. Baxter Continuous Glucose Monitoring (CGM) Product
Table 79. Baxter Recent Developments/Updates
Table 80. Abbott Laboratories Company Information
Table 81. Abbott Laboratories Description and Business Overview
Table 82. Abbott Laboratories Continuous Glucose Monitoring (CGM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Abbott Laboratories Continuous Glucose Monitoring (CGM) Product
Table 84. Abbott Laboratories Recent Developments/Updates
Table 85. Medtronic Company Information
Table 86. Medtronic Description and Business Overview
Table 87. Medtronic Continuous Glucose Monitoring (CGM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Medtronic Continuous Glucose Monitoring (CGM) Product
Table 89. Medtronic Recent Developments/Updates
Table 90. Animas Company Information
Table 91. Animas Description and Business Overview
Table 92. Animas Continuous Glucose Monitoring (CGM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Animas Continuous Glucose Monitoring (CGM) Product
Table 94. Animas Recent Developments/Updates
Table 95. Novo Nordisk Company Information
Table 96. Novo Nordisk Description and Business Overview
Table 97. Novo Nordisk Continuous Glucose Monitoring (CGM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Novo Nordisk Continuous Glucose Monitoring (CGM) Product
Table 99. Novo Nordisk Recent Developments/Updates
Table 100. Ypsomed Company Information
Table 101. Ypsomed Description and Business Overview
Table 102. Ypsomed Continuous Glucose Monitoring (CGM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Ypsomed Continuous Glucose Monitoring (CGM) Product
Table 104. Ypsomed Recent Developments/Updates
Table 105. GlySens Company Information
Table 106. GlySens Description and Business Overview
Table 107. GlySens Continuous Glucose Monitoring (CGM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. GlySens Continuous Glucose Monitoring (CGM) Product
Table 109. GlySens Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Continuous Glucose Monitoring (CGM) Distributors List
Table 113. Continuous Glucose Monitoring (CGM) Customers List
Table 114. Continuous Glucose Monitoring (CGM) Market Trends
Table 115. Continuous Glucose Monitoring (CGM) Market Drivers
Table 116. Continuous Glucose Monitoring (CGM) Market Challenges
Table 117. Continuous Glucose Monitoring (CGM) Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
Table 121. Authors List of This Report
List of Figures
Figure 1. Product Picture of Continuous Glucose Monitoring (CGM)
Figure 2. Global Continuous Glucose Monitoring (CGM) Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Continuous Glucose Monitoring (CGM) Market Share by Type: 2024 & 2031
Figure 4. Transmitters Product Picture
Figure 5. Sensors Product Picture
Figure 6. Insulin Pumps Product Picture
Figure 7. Global Continuous Glucose Monitoring (CGM) Market Value by Application (2020-2031) & (US$ Million)
Figure 8. Global Continuous Glucose Monitoring (CGM) Market Share by Application: 2024 & 2031
Figure 9. Hospitals
Figure 10. Homecare Settings
Figure 11. Others
Figure 12. Global Continuous Glucose Monitoring (CGM) Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Continuous Glucose Monitoring (CGM) Market Size (2020-2031) & (US$ Million)
Figure 14. Global Continuous Glucose Monitoring (CGM) Sales (2020-2031) & (K Units)
Figure 15. Global Continuous Glucose Monitoring (CGM) Average Price (USD/Unit) & (2020-2031)
Figure 16. Continuous Glucose Monitoring (CGM) Report Years Considered
Figure 17. Continuous Glucose Monitoring (CGM) Sales Share by Manufacturers in 2024
Figure 18. Global Continuous Glucose Monitoring (CGM) Revenue Share by Manufacturers in 2024
Figure 19. Global 5 and 10 Largest Continuous Glucose Monitoring (CGM) Players: Market Share by Revenue in Continuous Glucose Monitoring (CGM) in 2024
Figure 20. Continuous Glucose Monitoring (CGM) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 21. Global Continuous Glucose Monitoring (CGM) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 22. North America Continuous Glucose Monitoring (CGM) Sales Market Share by Country (2020-2031)
Figure 23. North America Continuous Glucose Monitoring (CGM) Revenue Market Share by Country (2020-2031)
Figure 24. U.S. Continuous Glucose Monitoring (CGM) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Canada Continuous Glucose Monitoring (CGM) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Europe Continuous Glucose Monitoring (CGM) Sales Market Share by Country (2020-2031)
Figure 27. Europe Continuous Glucose Monitoring (CGM) Revenue Market Share by Country (2020-2031)
Figure 28. Germany Continuous Glucose Monitoring (CGM) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. France Continuous Glucose Monitoring (CGM) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. U.K. Continuous Glucose Monitoring (CGM) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Italy Continuous Glucose Monitoring (CGM) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Russia Continuous Glucose Monitoring (CGM) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Asia Pacific Continuous Glucose Monitoring (CGM) Sales Market Share by Region (2020-2031)
Figure 34. Asia Pacific Continuous Glucose Monitoring (CGM) Revenue Market Share by Region (2020-2031)
Figure 35. China Continuous Glucose Monitoring (CGM) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Japan Continuous Glucose Monitoring (CGM) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. South Korea Continuous Glucose Monitoring (CGM) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. India Continuous Glucose Monitoring (CGM) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Australia Continuous Glucose Monitoring (CGM) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Taiwan Continuous Glucose Monitoring (CGM) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Indonesia Continuous Glucose Monitoring (CGM) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Thailand Continuous Glucose Monitoring (CGM) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Malaysia Continuous Glucose Monitoring (CGM) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Philippines Continuous Glucose Monitoring (CGM) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Latin America Continuous Glucose Monitoring (CGM) Sales Market Share by Country (2020-2031)
Figure 46. Latin America Continuous Glucose Monitoring (CGM) Revenue Market Share by Country (2020-2031)
Figure 47. Mexico Continuous Glucose Monitoring (CGM) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Brazil Continuous Glucose Monitoring (CGM) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Argentina Continuous Glucose Monitoring (CGM) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Middle East and Africa Continuous Glucose Monitoring (CGM) Sales Market Share by Country (2020-2031)
Figure 51. Middle East and Africa Continuous Glucose Monitoring (CGM) Revenue Market Share by Country (2020-2031)
Figure 52. Turkey Continuous Glucose Monitoring (CGM) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Saudi Arabia Continuous Glucose Monitoring (CGM) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. U.A.E Continuous Glucose Monitoring (CGM) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Global Sales Market Share of Continuous Glucose Monitoring (CGM) by Type (2020-2031)
Figure 56. Global Revenue Market Share of Continuous Glucose Monitoring (CGM) by Type (2020-2031)
Figure 57. Global Continuous Glucose Monitoring (CGM) Price (USD/Unit) by Type (2020-2031)
Figure 58. Global Sales Market Share of Continuous Glucose Monitoring (CGM) by Application (2020-2031)
Figure 59. Global Revenue Market Share of Continuous Glucose Monitoring (CGM) by Application (2020-2031)
Figure 60. Global Continuous Glucose Monitoring (CGM) Price (USD/Unit) by Application (2020-2031)
Figure 61. Continuous Glucose Monitoring (CGM) Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global AC Signal Relays Market Research Report 2025
Aug 20, 25
Global DC Signal Relays Market Research Report 2025
Aug 20, 25
Global High-Frequency Signal Relays Market Research Report 2025
Aug 20, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232